Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
3921
7058
6081
12162
15819
31599
399
599
7848
15696
450
750
480
849
4949
9899
300
999
197
217
20743
33457
577
648
1782
2200
235
0
10369
20699
4949
8999